You are using an older browser version. Please use a supported version for the best MSN experience.

Ascletis Pharma CEO on IPO Performance, New Drugs, Revenue Targets

Jan.17 -- Jason Wu, chairman and chief executive officer at Ascletis Pharma, discusses the company's performance since the IPO, their new drugs coming to market, competition in the industry, regulatory approvals, drug prices, revenue targets and what drugs he's most excited about. He speaks on "Bloomberg Markets: Asia."



Recent Videos

Featured Partners

image beaconimage beaconimage beacon